Start › Rak jelita grubego i odbytnicy › Wirginia › Arlington
Badania kliniczne dla Rak jelita grubego i odbytnicy w mieście Arlington, VA
52 badań dla Rak jelita grubego i odbytnicy szuka uczestników w ośrodkach w mieście Arlington i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
RekrutacjaFaza 1
- NEXT Oncology Virginia, Fairfax · 11 mi dalej
The Vanguard Study: Testing a New Way to Screen for Cancer
RekrutacjaZapraszamy zdrowych ochotników
- Inova Schar Cancer Institute, Fairfax · 11 mi dalej
- Inova Fair Oaks Hospital, Fairfax · 11 mi dalej
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
RekrutacjaFaza 2
- Virginia Cancer Specialists, Fairfax · 11 mi dalej
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1
- Inova Schar Cancer Institute, Fairfax · 11 mi dalej
- NEXT Virginia, Fairfax · 11 mi dalej
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekrutacjaFaza 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi dalej
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
RekrutacjaFaza 1/2
- Inova Schar Cancer Institute, Fairfax · 11 mi dalej
- Virginia Cancer Specialists, PC, Fairfax · 11 mi dalej
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
RekrutacjaFaza 1
- ALX Center 2, Fairfax · 11 mi dalej
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RekrutacjaFaza 3
- Virginia Cancer Specialists, PC, Arlington
- Virginia Cancer Specialists, PC, Fairfax · 11 mi dalej
- Virginia Cancer Specialists, PC, Reston · 14 mi dalej
- i 1 więcej
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
RekrutacjaFaza 1/2
- NEXT Oncology, Fairfax · 11 mi dalej
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
RekrutacjaFaza 2
- Virginia Cancer Specialists - Fairfax /ID# 271351, Fairfax · 11 mi dalej
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
RekrutacjaFaza 3
- Virginia Cancer Specialists, Arlington
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
RekrutacjaFaza 3
- Virginia Cancer Specialists, Arlington
- Inova Schar Cancer Institute Dept of Fairfax Hospital, Fairfax · 11 mi dalej
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
RekrutacjaFaza 2/3
- Local Institution - 0278, Fairfax · 11 mi dalej
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RekrutacjaFaza 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi dalej
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekrutacjaFaza 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi dalej
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RekrutacjaFaza 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · 11 mi dalej
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RekrutacjaFaza 1
- NEXT - Virginia, Fairfax · 11 mi dalej
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RekrutacjaFaza 1/2
- NEXT Virginia, Fairfax · 11 mi dalej
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
RekrutacjaFaza 1
- NEXT Oncology, Fairfax · 11 mi dalej
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
RekrutacjaFaza 3
- Clinical Study Site, Fairfax · 11 mi dalej
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
RekrutacjaFaza 2
- Inova Schar Cancer, Fairfax · 11 mi dalej
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1
- NEXT Virginia, Fairfax · 11 mi dalej
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
RekrutacjaFaza 1
- NEXT Virginia, Fairfax · 11 mi dalej
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
RekrutacjaFaza 1
- NEXT Oncology, Fairfax · 11 mi dalej
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
RekrutacjaFaza 1
- NEXT Virginia, Fairfax · 11 mi dalej
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
RekrutacjaFaza 1/2
- Clinical Trial Site, Fairfax · 11 mi dalej
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RekrutacjaFaza 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi dalej
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
RekrutacjaFaza 1/2
- NEXT Virginia, Fairfax · 11 mi dalej
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi dalej
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1
- Next Virginia, Fairfax · 11 mi dalej
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RekrutacjaFaza 1
- Virginia Cancer Specialists, Fairfax · 11 mi dalej
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
RekrutacjaFaza 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586, Fairfax · 11 mi dalej
- Virginia Cancer Specialists - Fairfax /ID# 274339, Fairfax · 11 mi dalej
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
RekrutacjaFaza 1
- NEXT Virginia, Fairfax · 11 mi dalej
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
RekrutacjaFaza 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi dalej
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RekrutacjaFaza 1
- NEXT Virginia, Fairfax · 11 mi dalej
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RekrutacjaFaza 1
- NEXT Texas LLC - Virginia, Fairfax · 11 mi dalej
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
RekrutacjaFaza 1
- NEXT Virginia, Fairfax · 11 mi dalej
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
RekrutacjaFaza 1
- Research Site, Fairfax · 11 mi dalej
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekrutacjaFaza 1
- NEXT Oncology Virginia, Fairfax · 11 mi dalej
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
RekrutacjaFaza 1/2
- NEXT Virginia, Fairfax · 11 mi dalej
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
RekrutacjaFaza 1
- NEXT Oncology Virginia, Fairfax · 11 mi dalej
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekrutacjaFaza 1/2
- Next Oncology Virginia, Fairfax · 11 mi dalej
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
RekrutacjaFaza 1/2
- NEXT Virginia, Fairfax · 11 mi dalej
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
RekrutacjaFaza 1
- NEXT Virginia, LLC, Fairfax · 11 mi dalej
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RekrutacjaFaza 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi dalej
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RekrutacjaFaza 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi dalej
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
RekrutacjaFaza 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi dalej
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1/2
- NEXT Virginia, Fairfax · 11 mi dalej
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
RekrutacjaFaza 1/2
- NEXT, Virginia, Fairfax · 11 mi dalej
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
RekrutacjaFaza 1
- NEXT Virginia, Fairfax · 11 mi dalej
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
RekrutacjaFaza 1
- Virginia Cancer Specialists, Fairfax · 11 mi dalej
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
RekrutacjaFaza 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · 11 mi dalej
Badania dla Rak jelita grubego i odbytnicy w innych miastach
- Houston, TX102 badań
- New York City, NY78 badań
- Nashville, TN69 badań
- Boston, MA63 badań
- Los Angeles, CA59 badań
- St. Louis, MO50 badań
- San Antonio, TX46 badań
- Philadelphia, PA44 badań
- Grand Rapids, MI40 badań
- Baldwin Park, CA37 badań
- Chicago, IL34 badań
- Tampa, FL34 badań
Inne badania w mieście Arlington
- Niedrobnokomórkowy rak płuca104 badań
- Nowotwór przerzutowy53 badań
- Nowotwory (wszystkie typy)48 badań
- Rak piersi47 badań
- Rak jajnika46 badań
- Rak płuc41 badań
- Rak endometrium39 badań
- Rak trzustki33 badań
- Rak płaskonabłonkowy głowy i szyi26 badań
- Niedrobnokomórkowy rak płuca23 badań
- Nowotwór żołądka20 badań
- Rak piersi potrójnie ujemny20 badań
Źródło: ClinicalTrials.gov, dane pobrane 6 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.